Povetacicept
VX25-AIS-301
Phase 2 small_molecule active
Quick answer
Povetacicept for Myasthenia Gravis, Generalized is a Phase 2 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Myasthenia Gravis, Generalized
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active